Side Navigation

X

CLSI QMS19

Customer Focus in a Quality Management System, 1st Edition, QMS19Ed1E
standard by Clinical and Laboratory Standards Institute, 09/01/2017

CLSI NBS04

Newborn Screening by Tandem Mass Spectrometry, NBS04Ed2E
standard by Clinical and Laboratory Standards Institute, 05/01/2017

CLSI QMS17

External Assessment, Audits, and Inspections of the Laboratory, 1st Edition, QMS17Ed1E
standard by Clinical and Laboratory Standards Institute, 08/01/2017

CLSI EP12-A2

User Protocol for Evaluation of Qualitative Test Performance; Approved Guideline, Second Edition, EP122A
standard by Clinical and Laboratory Standards Institute, 01/01/2008

CLSI VET01-A4 and VET01-S3

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacterial Isolated from Animals; Approved Standard-Fourth Edition and Supplement, VET01A4E and VET01S3E
standard by Clinical and Laboratory Standards Institute, 06/01/2015

CLSI M44-A2

Method for Antifungal Disk Diffusion Susceptibility Testing of Yeasts: Approved Guideline–Second Edition, M44A2
standard by Clinical and Laboratory Standards Institute, 05/01/2009

CLSI NBS06-A

Newborn Blood Spot Screening for Severe Combined Immunodeficiency by Measurement of T-cell Receptor Excision Circles; Approved Guideline, NBS06AE
standard by Clinical and Laboratory Standards Institute, 04/01/2013

CLSI QMS14-A (R2018)

Quality Management System: Leadership and Management Roles and Responsibilities; Approved Guideling, QMS14AE
standard by Clinical and Laboratory Standards Institute, 12/01/2012

CLSI MM02A2

Immunoglobin and T-Cell Receptor Gene Rearrangement Assays; Approved Guideline, MM02-A2
standard by Clinical and Laboratory Standards Institute, 08/01/2002

CLSI EP07

Interference Testing in Clinical Chemistry; 3rd Edition, EP07Ed3E
standard by Clinical and Laboratory Standards Institute, 04/01/2018